Oragenics, Inc.
OGEN
$4.05
$0.5616.05%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.54% | 73.73% | -22.36% | 24.44% | 13.85% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -199.28% | -99.47% | -13.06% | -8.49% | -13.38% |
| Change in Net Operating Assets | 97.19% | 50.01% | 29.86% | 76.02% | -205.88% |
| Cash from Operations | 31.07% | -83.07% | -31.09% | 40.06% | -45.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.22% | -45.43% | 0.08% | -17.52% | -16.33% |
| Issuance of Common Stock | 43.33% | 1,900.00% | 356.97% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 182.47% | -44.46% | 414.37% | 861.08% | 1,134.23% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 281.10% | 0.17% | 353.87% | 73.05% | 37.78% |